Form 4: Invivyd Director Terrance McGuire Acquires Stock Options

Terrance McGuire, a director of Invivyd, Inc., was granted stock options to purchase 50,000 shares of common stock.

Summary

• Terrance McGuire, a director at Invivyd, Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 20, 2025, McGuire was granted stock options for 50,000 shares of Invivyd's common stock at an exercise price of $0.8092 per share.
• The options vest fully on the earlier of May 20, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon continuous service through the vesting date.
• The options expire on May 19, 2035.

Sentiment

Score: 6

Explanation: The document is a routine filing related to stock option grants, which is generally neutral. It indicates alignment of director's interests with shareholders.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

Keywords

Form 4, Invivyd, Stock Options, Director, Beneficial Ownership, Terrance McGuire